Bone Metastases News

This RSS feed URL is deprecated


This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news

A new weapon against bone metastasis? Princeton lab develops antibody to fight cancer - Princeton University



Princeton University
 
A new weapon against bone metastasis? Princeton lab develops antibody to fight cancer 
Princeton University
?Our project specifically looked at bone metastasis and how cancer cells and bone cells 'talk' to each other through molecular signaling,? said Rebecca Tang, Class of 2016, who worked with Kang for three years and is now a medical student at the ...

and more » 


Bisphosphonates vs Denosumab: Preventing SREs in Breast Cancer With Bone Metastasis - Oncology Nurse Advisor



Oncology Nurse Advisor
 
Bisphosphonates vs Denosumab: Preventing SREs in Breast Cancer With Bone Metastasis 
Oncology Nurse Advisor
Bone is a common site of metastases in patients with breast cancer. It is rarely cured and commonly treated with bisphosphonates and the human monoclonal RANKL-antibody denosumab, which delay its progression and improve quality of life. Researchers ...

 


Bayer sticks to bone metastasis drug estimate after setback - Reuters



Medscape
 
Bayer sticks to bone metastasis drug estimate after setback 
Reuters
BERLIN, Dec 1 (Reuters) - Bayer is sticking to its peak sales estimate for bone metastasis drug Xofigo despite a setback in a late-stage drug trial, the head of the German group's pharmaceuticals unit said on Friday. In a trial, which was designed to ...
Concern Over Adverse Events in Prostate Cancer Trial Medscape
Bayer unblinds cancer drug study early to investigate patient deaths BioPharma Dive

all 4 news articles » 


Risk factors for bone metastasis from renal cell cancer. - UroToday



Risk factors for bone metastasis from renal cell cancer. 
UroToday
The prognosis for renal cell carcinoma (RCC) is related to a high rate of metastasis, including 30% of bone metastasis. In this study, we investigate the correlation between diverse clinical factors and bone metastases secondary from renal cell cancer ...

 


Excretion and whole-body retention of radium-223 dichloride administered for the treatment of bone metastases from ... - UroToday



Excretion and whole-body retention of radium-223 dichloride administered for the treatment of bone metastases from ... 
UroToday
The aim of the study was to determine the fraction of administered activity that was excreted and retained by a small cohort of patients who each received treatment with radium-223 dichloride (Ra). Ra is an ?-emitting radionuclide that has been ...

 


Sites of metastasis and overall survival in esophageal cancer: a population-based study - Dove Medical Press



Sites of metastasis and overall survival in esophageal cancer: a population-based study 
Dove Medical Press
Results: We included 3218 patients in this study; the most common site of DM was the liver, followed by distant lymph nodes, lung, bone and brain. Median OS for patients with liver, distant lymph node, lung, bone, and brain metastases was 5, 10, 6, 4 ...

 


Cryoablation of Bone Metastases from Renal Cell Carcinoma for Local Tumor Control. - UroToday



Cryoablation of Bone Metastases from Renal Cell Carcinoma for Local Tumor Control. 
UroToday
Patients with bone metastases from renal cell carcinoma often are not surgical candidates and have a poor prognosis. There are limited data on the use of cryoablation as a locoregional therapy for bone metastases. Our objective was to assess the local ...

 


Will Pegg will die an assisted death. He couldn't feel more alive - CBC.ca



CBC.ca
 
Will Pegg will die an assisted death. He couldn't feel more alive 
CBC.ca
Will Pegg, of Victoria, was diagnosed with metastatic bone cancer in January 2017. He has over 200 metastases on his bones, spine, pelvis, ribs and skull behind his left eye. He knew he didn't want to die in pain, so he chose an assisted death ...

 


Poor Prognostic Markers Predict for Abemaciclib Benefit in Patients With Breast Cancer - Cancer Therapy Advisor



Cancer Therapy Advisor
 
Poor Prognostic Markers Predict for Abemaciclib Benefit in Patients With Breast Cancer 
Cancer Therapy Advisor
Prognostic variables included performance status, tumor grade, progesterone receptor status, liver metastases, and bone-only metastases. ORR benefit was associated with negative progesterone receptor status, the presence of liver metastases, and tumor ...

and more » 


Breast Cancer Advisor - Cancer Therapy Advisor



Cancer Therapy Advisor
 
Breast Cancer Advisor 
Cancer Therapy Advisor
Patients with lung metastases may complain of shortness of breath and have an abnormal pulmonary exam. Liver metastases may present with jaundice, nausea, vomiting, and right upper quadrant abdominal pain on exam. Bone metastases will frequently cause ...